Perspectiva general

The Drug Development Phase 2 module is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners will learn about the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.

Estimated time to complete module: 1.25 hours

This eLearning module can be purchased individually or as part of the Drug Development and Lifecycle Management eLearning Program.

Temas destacados

Objectives and key players
Regulatory activities
Clinical R&D and biostatistics activities
Case study part 1
End of phase 2
Case study part 2
Review

¿Quiénes deben asistir?

This module is designed for individuals who are new to, or changing roles in, the pharmaceutical and biotechnology industries. The module will also benefit professionals who work in the areas of:

Objetivos de aprendizaje

At the conclusion of this course, participants should be able to:
- List the key objectives and activities of phase 2
- Recognize the regulatory activities and decisions that occur during phase 2
- Identify risk-return decisions involved in phase 2

¿Tiene una cuenta?

Registrarse

Drug Development Phase 2

Perspectiva general

Temas destacados

¿Quiénes deben asistir?

Objetivos de aprendizaje

Be informed and stay engaged.